Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway

Mesenchymal stromal cells (MSCs) have been considered a promising alternative for treatment of acute respiratory distress syndrome (ARDS). However, there is significant heterogeneity in their therapeutic efficacy, largely owing to the incomplete understanding of the mechanisms underlying the therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoran, Wei, Xuxia, Deng, Yiwen, Yuan, Xiaofeng, Shi, Jiahao, Huang, Weijun, Huang, Jing, Chen, Xiaoyong, Zheng, Shuwei, Chen, Jieying, Chen, Keyu, Xu, Ruiming, Wang, Hongmiao, Li, Weiqiang, Li, Shiyue, Yi, Huimin, Xiang, Andy Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441842/
https://www.ncbi.nlm.nih.gov/pubmed/36064538
http://dx.doi.org/10.1038/s41392-022-01124-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441842/
https://www.ncbi.nlm.nih.gov/pubmed/36064538
http://dx.doi.org/10.1038/s41392-022-01124-6

Ejemplares similares